Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms

Mie Suzuki-Okutani(The University of Osaka), Hirotaka Ebina(The University of Osaka)

bioRxiv (Cold Spring Harbor Laboratory)

March 4, 2024

10.1101/2024.03.03.582873

Cited by 0

Related Papers

1mΨ influences the performance of various positive-stranded RNA virus-based replicons

|Scientific Reports|2024|11

Protocol to isolate temperature-sensitive SARS-CoV-2 mutants and identify associated mutations

|STAR Protocols|2023|6

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms

|eLife|2024|1